Astra Zeneca plans to exit manufacturing at Bangalore

AstraZeneca Pharma will exit manufacturing at its only plant based in Bangalore, as part of a ``global strategic review’’. The company with revenues of over Rs 1000 crore, feels that it can derive more value for its shareholders by transferring core manufacturing to a contract manufacturer. As a part of AstraZeneca's ongoing strategic review of its global manufacturing and supply network, the company intends to exit the manufacturing site in Bangalore, in due course, it said in a stock exchange filing.

from Astra Zeneca plans to exit manufacturing at Bangalore https://ift.tt/cQDFpSa https://ift.tt/zq8rt1G